UTAH CARDIAC TRANSPLANT TEAM REPORTS PROMISING NEW TREATMENT FOR HEART TRANSPLANT REJECTION

Update Item Information
Title UTAH CARDIAC TRANSPLANT TEAM REPORTS PROMISING NEW TREATMENT FOR HEART TRANSPLANT REJECTION
Subject Academic Medical Centers; Hospitals, University; Public Relations; Communications Media; Mass Media; Social Marketing; Information Dissemination; News; Press Release
Description HELSINKI, FINLAND-The UTAH Cardiac Transplant Program presented data Sunday, Aug. 3, at the International Congress of the Transplantation Society in Helsinki, Finland, indicating that Orthoclone OKT&h monoclonal antibody, a genetic engineering product, was highly effective in treating heart transplant rejection that was resistant to conventional therapies and appears to be effective in preventing rejection when used as a prophylaxis.
Publisher University of Utah Health Care Office of Public Affairs and Marketing
Date 1986-08-03
Language eng
Relation University of Utah Health Care Office of Public Affairs and Marketing Collection
Rights Management Copyright 2012
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Relation is Part of Press Releases; University of Utah Health Sciences Center News
Type Text
ARK ark:/87278/s60k54g6
Setname ehsl_pahsc
ID 935023
Reference URL https://collections.lib.utah.edu/ark:/87278/s60k54g6
Back to Search Results